Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BOM:524400's Gross Margin % is ranked worse than 81.08% of 941
companies
in the Drug Manufacturers industry
Industry Median: 48.54
vs BOM:524400: 29.66
Ishita Drugs And Industries had a gross margin of 25.42% for the quarter that ended in Mar. 2026 => Competition eroding margins
Ishita Drugs And Industries (BOM:524400) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Ishita Drugs And Industries had a gross margin of 25.42% for the quarter that ended in Mar. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Ishita Drugs And Industries Gross Margin % Related Terms
Ishita Drugs And Industries Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:524400 vs ZTS, UTHR: Gross Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Ishita Drugs And Industries's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ishita Drugs And Industries Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Ishita Drugs And Industries's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Ishita Drugs And Industries's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Ishita Drugs And Industries (BOM:524400) has a Gross Margin % of 25.42% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Ishita Drugs And Industries and its competitors. This is near median its historical median of 24.32. Over the past decade, Ishita Drugs And Industries' Gross Margin % has ranged from 18.47 to 29.66. According to the industry distribution chart, Ishita Drugs And Industries ranks #763 out of 941 companies in the Drug Manufacturers industry, placing it in the top 81.1%.
Is Ishita Drugs And Industries' Gross Margin % too high?
Ishita Drugs And Industries' current Gross Margin % of 25.42% is near median its 10-year median of 24.32. Over the past 10 years, this metric has ranged from a low of 18.47 to a high of 29.66. The Drug Manufacturers industry median Gross Margin % is 48.54. Ishita Drugs And Industries' value of 25.42% is 47.6% below this industry median. Based on the distribution chart, Ishita Drugs And Industries ranks #763 out of 941 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Ishita Drugs And Industries has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ishita Drugs And Industries' Gross Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Ishita Drugs And Industries ranks #763 out of 941 companies for Gross Margin %. This places Ishita Drugs And Industries in the lower half of its industry. The industry median Gross Margin % is 48.54. Ishita Drugs And Industries' value of 25.42% is 47.6% below this benchmark. Historically, Ishita Drugs And Industries' own Gross Margin % has ranged from 18.47 to 29.66 over the past decade. While the company's 10-year median is 24.32 vs. the industry median of 48.54, Ishita Drugs And Industries has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.54, based on 941 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ishita Drugs And Industries's current Gross Margin % of 25.42% is 47.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Ishita Drugs And Industries and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ishita Drugs And Industries's current Gross Margin % is 25.42%, which is near median its own 10-year median of 24.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ishita Drugs And Industries stock overvalued right now?
Based on GuruFocus' analysis, Ishita Drugs And Industries (BOM:524400) is currently considered Fairly Valued. The stock's GF Value™ is ₹78.36, compared to a current price of ₹71.79 — trading 8.4% below its estimated fair value. The current Gross Margin % is 25.42%, which is near median its 10-year median of 24.32 and 47.6% below the Drug Manufacturers industry median of 48.54. Ishita Drugs And Industries' overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Ishita Drugs And Industries (BOM:524400), the current Gross Margin % is 25.42% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ishita Drugs And Industries (BOM:524400) Overvalued in 2026?
Based on GuruFocus' analysis, Ishita Drugs And Industries stock appears to be undervalued.
The current stock price of ₹71.79 is trading 8.4% below its estimated GF Value™ of ₹78.36.
GuruFocus considers Ishita Drugs And Industries to be Fairly Valued.
Key valuation signals for BOM:524400:
Gross Margin %: 25.42% (near median its 10-year median of 24.32)
GF Value™: ₹78.36 vs. price of ₹71.79 (8.4% below fair value)
Industry Position: 47.6% below the Drug Manufacturers median (#763 of 941)
No single metric tells the full story. See the BOM:524400 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ishita Drugs And Industries Ltd is engaged in the business of manufacturing various APIs and drug intermediates. The company supplies its products to various pharmaceutical companies and is also being exported to various countries across the world. The company has three manufacturing facilities located in the state of Gujarat, two for APIs and drug intermediates at Ahmedabad and Surendranagar, and one for finished pharmaceutical formulations at Mehsana.
73GF Score
Get the complete analysis for BOM:524400
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524400 has been successfully added to your 
